Der Kaninchen Polyklonal anti-VLDLR Antikörper wird verwendet zum Nachweis von VLDLR in Proben von Human, Ratte und Maus. Er wurde validiert für WB und ELISA.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Konservierungsmittel
ProClin
Vorsichtsmaßnahmen
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
VLDLR
(Very Low Density Lipoprotein Receptor (VLDLR))
Andere Bezeichnung
VLDLR
Hintergrund
Very low-density lipoprotein receptor, VLDL receptor, VLDL-RVLDLR (Very Low Density Lipoprotein Receptor) is a Protein Coding gene. Diseases associated with VLDLR include Cerebellar Hypoplasia And Mental Retardation With Or Without Quadrupedal Locomotion 1 and Cerebellar Hypoplasia. Among its related pathways are Metabolism and Lipoprotein metabolism. The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. VLDLR encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Alternative splicing generates multiple transcript variants encoding distinct isoforms for VLDLR.